Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our opinions or reviews. Learn how we make money.

How to buy PMV Pharmaceuticals stock | 35.99

Own PMV Pharmaceuticals stock in just a few minutes.

Updated . What changed?

Fact checked

PMV Pharmaceuticals, Inc. is a biotechnology business based in the US. PMV Pharmaceuticals shares (PMVP) are listed on the NASDAQ and all prices are listed in US Dollars. PMV Pharmaceuticals employs 38 staff and has a market cap (total outstanding shares value) of USD$1.7 billion.

How to buy shares in PMV Pharmaceuticals

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for PMV Pharmaceuticals. Find the stock by name or ticker symbol: PMVP. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until PMV Pharmaceuticals reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. At last close price of USD$35.99, weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of PMV Pharmaceuticals, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of PMV Pharmaceuticals. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

PMV Pharmaceuticals share price

Use our graph to track the performance of PMVP stocks over time.

PMV Pharmaceuticals shares at a glance

Information last updated 2020-10-19.
Latest market closeUSD$35.99
52-week rangeUSD$31.5 - USD$40.97
50-day moving average USD$35.2475
200-day moving average USD$35.2475
Wall St. target priceN/A
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) N/A

Compare trading platforms

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee
Vanguard
$0
Stocks, Mutual funds, ETFs, Forex
$1
$20 per year
Get a personal advisor when you open an account with at least $50,000.
Robinhood
$0
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Sofi Invest
$0
Stocks
N/A
0%
A free way to invest in stocks, ETFs and crypto.
Tastyworks
$0
Stocks, Options, ETFs, Futures
Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg
Futures: $2.50/contract to open, $0 to close
0%
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Interactive Brokers
$0
Stocks, Bonds, Options, Mutual funds, Index funds, ETFs, Futures, Cash
$0 + $0.65/contract, $1 minimum
0%
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
TD Ameritrade
$0
or $25 broker-assisted
Stocks
$0 + $0.65/contract,
or $25 broker-assisted
TD Ameritrade features $0 commission for online stock, but watch out for high short-term ETF and broker-assisted trading fees.
loading

Compare up to 4 providers

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy PMV Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

PMV Pharmaceuticals price performance over time

Historical closes compared with the close of $35.99 from 2020-10-16

1 week (2020-10-22) 2.48%
1 month (2020-09-29) -5.29%
3 months (2020-07-25) N/A
6 months (2020-04-25) N/A
1 year (2019-10-25) N/A
2 years (2018-10-25) N/A
3 years (2017-10-25) N/A
5 years (2015-10-25) N/A

PMV Pharmaceuticals financials

Gross profit TTM USD$0
Return on assets TTM 0%
Return on equity TTM 0%
Profit margin 0%
Book value N/A
Market capitalisation USD$1.7 billion

TTM: trailing 12 months

Shorting PMV Pharmaceuticals shares

There are currently 186,922 PMV Pharmaceuticals shares held short by investors – that's known as PMV Pharmaceuticals's "short interest". This figure is up from 0 last month.

There are a few different ways that this level of interest in shorting PMV Pharmaceuticals shares can be evaluated.

PMV Pharmaceuticals's "short interest ratio" (SIR)

PMV Pharmaceuticals's "short interest ratio" (SIR) is the quantity of PMV Pharmaceuticals shares currently shorted divided by the average quantity of PMV Pharmaceuticals shares traded daily (recently around 1.2 million). PMV Pharmaceuticals's SIR currently stands at 0.16. In other words for every 100,000 PMV Pharmaceuticals shares traded daily on the market, roughly 160 shares are currently held short.

To gain some more context, you can compare PMV Pharmaceuticals's short interest ratio against those of similar companies.

  • Exact Sciences Corporation (EXAS.US): 5.26
  • Blueprint Medicines Corporation (BPMC.US): 7.68
  • Moderna (MRNA.US): 3.36

However PMV Pharmaceuticals's short interest can also be evaluated against the total number of PMV Pharmaceuticals shares, or, against the total number of tradable PMV Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case PMV Pharmaceuticals's short interest could be expressed as 0% of the outstanding shares (for every 100,000 PMV Pharmaceuticals shares in existence, roughly 0 shares are currently held short) or 0.0065% of the tradable shares (for every 100,000 tradable PMV Pharmaceuticals shares, roughly 7 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against PMV Pharmaceuticals.

Find out more about how you can short PMV Pharmaceuticals stock.

PMV Pharmaceuticals share dividends

We're not expecting PMV Pharmaceuticals to pay a dividend over the next 12 months.

PMV Pharmaceuticals overview

PMV Pharmaceuticals, Inc., a precision oncology company, discovery and development of small molecule, tumor-agnostic therapies for p53 mutations in cancer. Its lead product candidate is PC14586, a small molecule that corrects and restores p53 function. The company also develops product candidates for p53 R273H hotspot mutation and other p53 hotspot mutations. PMV Pharmaceuticals, Inc. was formerly known as PJ Pharmaceuticals, Inc. and changed to in July 2013. The company was founded in 2013 and is headquartered in Cranbury, New Jersey.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site